Phosphodiesterase-5 Inhibitors: Future Perspectives

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|30|3540-3551

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.30, 2009-10, pp. : 3540-3551

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ADMET considerations for phosphodiesterase-5 inhibitors

By Rezvanfar Mohammad Amin   Rahimi Hamid Reza   Abdollahi Mohammad  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 10, 2012-10 ,pp. : 1231-1245

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular Effects of Phosphodiesterase 5 Inhibitors

By  

Current Pharmaceutical Design, Vol. 12, Iss. 27, 2006-09 ,pp. : 3485-3494

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase 5 inhibitors and erectile dysfunction

By Sandner Peter   Svenstrup Niels   Tinel Hanna   Haning Helmut   Bischoff Erwin  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 1, 2008-01 ,pp. : 21-33

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase 4 Inhibitors in Immune-mediated Diseases: Mode of Action, Clinical Applications, Current and Future Perspectives

By  

Current Medicinal Chemistry, Vol. 24, Iss. 28, 2017-09 ,pp. : 3054-3067

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Phosphodiesterase 5 Inhibitors: Pharmacology and Therapeutic Perspectives (Executive Editor: Giuseppe Barbaro)]

By  

Current Pharmaceutical Design, Vol. 12, Iss. 27, 2006-09 ,pp. : 3437-3437

Bentham Science Publishers

Access to resources Recommend Favorite